Pharming Group (PHAR) News Today $10.49 +0.47 (+4.69%) Closing price 03:50 PM EasternExtended Trading$10.52 +0.03 (+0.29%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PHAR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Q2 EPS Estimates for Pharming Group Decreased by AnalystPharming Group (NASDAQ:PHAR - Free Report) - Analysts at HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for Pharming Group in a note issued to investors on Thursday, May 8th. HC Wainwright analyst J. Pantginis now expects that the company will earn ($0.20) per share for the quMay 13, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Up 13.9% on Strong EarningsMay 11, 2025 | americanbankingnews.comPharming Group First Quarter 2025 Earnings: US$0.022 loss per share (vs US$0.019 loss in 1Q 2024)May 10, 2025 | finance.yahoo.comPharming Group N.V. (PHAR) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comPharming Group N.V. 2025 Q1 - Results - Earnings Call PresentationMay 9, 2025 | seekingalpha.comPharming Group N.V.: Pharming Group reports first quarter 2025 financial results and provides business updateMay 8, 2025 | finanznachrichten.dePharming Group reports first quarter 2025 financial results and provides business update | ...May 8, 2025 | gurufocus.comEarnings To Watch: Pharming Group (PHGUF) Reports Q1 2025 ResultMay 7, 2025 | gurufocus.comPharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive DirectorApril 30, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Should You Buy?April 30, 2025 | marketbeat.comPharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of ...April 30, 2025 | gurufocus.comShort Interest in Pharming Group (NASDAQ:PHAR) Declines By 36.0%Pharming Group (NASDAQ:PHAR - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 1,600 shares, a decline of 36.0% from the March 31st total of 2,500 shares. Based on an average trading volume of 6,000 shares, the short-interest ratio is currently 0.3 days. Currently, 0.0% of the shares of the stock are short sold.April 30, 2025 | marketbeat.comPharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical ...April 25, 2025 | gurufocus.comPharming Group to Present Key Findings at Clinical Immunology Society MeetingApril 25, 2025 | tipranks.comPharming receives positive recommendation from NICE for Joenja®?(leniolisib) as a treatment for APDSApril 24, 2025 | tmcnet.comPharming Group to report first quarter 2025 financial results on May 8 | PHARM Stock NewsApril 24, 2025 | gurufocus.comPharming Group to report first quarter 2025 financial results on May 8 | PHARM Stock NewsApril 24, 2025 | gurufocus.comPharming Group (PHAR) Receives NICE Approval for Joenja in England and Wales | PHAR Stock NewsApril 23, 2025 | gurufocus.comPharming Group’s Joenja® Receives NICE Recommendation for APDS TreatmentApril 23, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Here's What HappenedPharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?April 23, 2025 | marketbeat.comPharming Group’s Strategic Expansion and NICE Endorsement Drive Buy RatingApril 23, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Shares Up 4.3% - Should You Buy?Pharming Group (NASDAQ:PHAR) Shares Up 4.3% - Here's What HappenedApril 18, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Short Interest Down 56.9% in MarchPharming Group (NASDAQ:PHAR - Get Free Report) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 2,500 shares, a decrease of 56.9% from the March 15th total of 5,800 shares. Based on an average daily volume of 6,500 shares, the short-interest ratio is presently 0.4 days. Approximately 0.0% of the shares of the company are sold short.April 18, 2025 | marketbeat.comEuropean Opportunities: 3 Penny Stocks With Market Caps Larger Than €10MApril 15, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Trading 10.3% Higher - Here's What HappenedPharming Group (NASDAQ:PHAR) Shares Up 10.3% - Time to Buy?April 9, 2025 | marketbeat.comPharming price target lowered to EUR 2 from EUR 2.15 at RBC CapitalApril 8, 2025 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What HappenedApril 4, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Time to Buy?April 1, 2025 | marketbeat.comPharming Group: Small Dutch Company With Strong RevenuesApril 1, 2025 | seekingalpha.comShort Interest in Pharming Group (NASDAQ:PHAR) Rises By 107.1%Pharming Group (NASDAQ:PHAR - Get Free Report) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 5,800 shares, a growth of 107.1% from the February 28th total of 2,800 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 6,700 shares, the short-interest ratio is presently 0.9 days.March 29, 2025 | marketbeat.comPharming Group to Engage Investors at April ConferencesMarch 28, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Trading Down 2% - Here's WhyPharming Group (NASDAQ:PHAR) Shares Down 2% - Here's What HappenedMarch 25, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Pharming Group (NASDAQ:PHAR)HC Wainwright reaffirmed a "buy" rating and issued a $37.00 target price on shares of Pharming Group in a report on Thursday.March 21, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's WhyPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy?March 20, 2025 | marketbeat.comPharming Group Begins Phase II Trial for CVID TreatmentMarch 20, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Trading Down 3.6% - What's Next?Pharming Group (NASDAQ:PHAR) Trading Down 3.6% - Should You Sell?March 18, 2025 | marketbeat.comWhat Analysts Are Saying About Pharming StockMarch 17, 2025 | benzinga.comPharming Group (NASDAQ:PHAR) Price Target Raised to $39.00 at OppenheimerOppenheimer lifted their target price on Pharming Group from $30.00 to $39.00 and gave the company an "outperform" rating in a research report on Friday.March 15, 2025 | marketbeat.comPharming Group's (PHAR) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $37.00 target price on shares of Pharming Group in a research note on Friday.March 15, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Up - Here's WhyMarch 14, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Releases Earnings Results, Misses Estimates By $0.02 EPSPharming Group (NASDAQ:PHAR - Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($0.02). Pharming Group had a negative net margin of 6.09% and a negative return on equity of 7.65%.March 14, 2025 | marketbeat.com3 European Penny Stocks With Market Caps Over €300MMarch 14, 2025 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Short Interest UpdatePharming Group (NASDAQ:PHAR - Get Free Report) saw a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 2,800 shares, a drop of 47.2% from the February 13th total of 5,300 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 7,100 shares, the days-to-cover ratio is currently 0.4 days.March 14, 2025 | marketbeat.comPharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...March 14, 2025 | gurufocus.comPharming Group outlines 2025 revenue guidance of $315M to $335M driven by RUCONEST and Joenja growthMarch 14, 2025 | msn.comPharming Group Full Year 2024 Earnings: EPS Beats ExpectationsMarch 14, 2025 | uk.finance.yahoo.comQ4 2024 Pharming Group NV Earnings Call TranscriptMarch 14, 2025 | gurufocus.comPharming Group N.V. (PHAR) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | seekingalpha.comPharming Group reports fourth quarter and full year 2024 financial results and provides business updateMarch 13, 2025 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Shares Up 6.3% - Here's WhyPharming Group (NASDAQ:PHAR) Trading 6.3% Higher - Here's What HappenedMarch 12, 2025 | marketbeat.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼-1.000.66▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼03▲PHAR Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLTX News Today IMVT News Today IBRX News Today XENE News Today AMRX News Today HCM News Today OGN News Today MIRM News Today APLS News Today ARWR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
